RGBOQ Projected Dividend Yield

ReGen Biologics Inc ( OTCBB : RGBOQ )

Regen Biologics is an orthopedic products company that develops, manufactures and markets tissue growth and repair products. Co.'s principal products are: the Menaflex™ collagen meniscus implant device, which is designed to facilitate growth of new tissue to reinforce existing meniscus tissue following partial meniscectomy in the human knee; and the SharpShooter® Tissue Repair System, a suturing device used to facilitate the surgical implantation of the Menaflex device, as well as to perform other similar arthroscopic meniscus repair procedures. Both devices are marketed outside the U.S., including in Italy, Spain, Andorra, Poland, Turkey, the Republic of South Africa, and the U.K.

20 YEAR PERFORMANCE RESULTS